Selected research
Industry Research
Nociceptin Receptor Industry Research Report 2026
Market perspective
The global Nociceptin Receptor market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Nociceptin Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Nociceptin Receptor is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Nociceptin Receptor is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Nociceptin Receptor include Serodus ASA, Orexigen Therapeutics Inc, Grunenthal GmbH, Fuso Pharmaceutical Industries Ltd and Blackthorn Therapeutics Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Nociceptin Receptor market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Nociceptin Receptor Market by Company
Serodus ASA
Orexigen Therapeutics Inc
Grunenthal GmbH
Fuso Pharmaceutical Industries Ltd
Blackthorn Therapeutics Inc
Nociceptin Receptor Segment by Type
GRTTA-2210
GRT-6010
Cebranopadol
BTRX-246040
AT-403
Others
Nociceptin Receptor Segment by Application
Major Depressive Disorder
Drug Addiction
Diabetic Neuropathic Pain
Postherpetic Neuralgia
Others
Nociceptin Receptor Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nociceptin Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nociceptin Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nociceptin Receptor.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Nociceptin Receptor manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Nociceptin Receptor by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Nociceptin Receptor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- GRTTA-2210
- GRT-6010
- Cebranopadol
- BTRX-246040
- AT-403
- Others
Applications
- Major Depressive Disorder
- Drug Addiction
- Diabetic Neuropathic Pain
- Postherpetic Neuralgia
- Others
Companies covered
- Serodus ASA
- Orexigen Therapeutics Inc
- Grunenthal GmbH
- Fuso Pharmaceutical Industries Ltd
- Blackthorn Therapeutics Inc
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Nociceptin Receptor Market Size (2021-2032)
- 2.2.2 Global Nociceptin Receptor Sales (2021-2032)
- 2.2.3 Global Nociceptin Receptor Market Average Price (2021-2032)
- 2.3 Nociceptin Receptor by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 GRTTA-2210
- 2.3.3 GRT-6010
- 2.3.4 Cebranopadol
- 2.3.5 BTRX-246040
- 2.3.6 AT-403
- 2.3.7 Others
- 2.4 Nociceptin Receptor by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Major Depressive Disorder
- 2.4.3 Drug Addiction
- 2.4.4 Diabetic Neuropathic Pain
- 2.4.5 Postherpetic Neuralgia
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Nociceptin Receptor Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Nociceptin Receptor Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Nociceptin Receptor Revenue of Manufacturers (2021-2026)
- 3.4 Global Nociceptin Receptor Average Price by Manufacturers (2021-2026)
- 3.5 Global Nociceptin Receptor Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Nociceptin Receptor, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Nociceptin Receptor, Product Type & Application
- 3.8 Global Manufacturers of Nociceptin Receptor, Established Date
- 3.9 Global Nociceptin Receptor Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Serodus ASA
- 4.1.1 Serodus ASA Company Information
- 4.1.2 Serodus ASA Business Overview
- 4.1.3 Serodus ASA Nociceptin Receptor Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Serodus ASA Nociceptin Receptor Product Portfolio
- 4.1.5 Serodus ASA Recent Developments
- 4.2 Orexigen Therapeutics Inc
- 4.2.1 Orexigen Therapeutics Inc Company Information
- 4.2.2 Orexigen Therapeutics Inc Business Overview
- 4.2.3 Orexigen Therapeutics Inc Nociceptin Receptor Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Orexigen Therapeutics Inc Nociceptin Receptor Product Portfolio
- 4.2.5 Orexigen Therapeutics Inc Recent Developments
- 4.3 Grunenthal GmbH
- 4.3.1 Grunenthal GmbH Company Information
- 4.3.2 Grunenthal GmbH Business Overview
- 4.3.3 Grunenthal GmbH Nociceptin Receptor Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Grunenthal GmbH Nociceptin Receptor Product Portfolio
- 4.3.5 Grunenthal GmbH Recent Developments
- 4.4 Fuso Pharmaceutical Industries Ltd
- 4.4.1 Fuso Pharmaceutical Industries Ltd Company Information
- 4.4.2 Fuso Pharmaceutical Industries Ltd Business Overview
- 4.4.3 Fuso Pharmaceutical Industries Ltd Nociceptin Receptor Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Fuso Pharmaceutical Industries Ltd Nociceptin Receptor Product Portfolio
- 4.4.5 Fuso Pharmaceutical Industries Ltd Recent Developments
- 4.5 Blackthorn Therapeutics Inc
- 4.5.1 Blackthorn Therapeutics Inc Company Information
- 4.5.2 Blackthorn Therapeutics Inc Business Overview
- 4.5.3 Blackthorn Therapeutics Inc Nociceptin Receptor Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Blackthorn Therapeutics Inc Nociceptin Receptor Product Portfolio
- 4.5.5 Blackthorn Therapeutics Inc Recent Developments
5 Global Nociceptin Receptor Market Scenario by Region
- 5.1 Global Nociceptin Receptor Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Nociceptin Receptor Sales by Region: 2021-2032
- 5.2.1 Global Nociceptin Receptor Sales by Region: 2021-2026
- 5.2.2 Global Nociceptin Receptor Sales by Region: 2027-2032
- 5.3 Global Nociceptin Receptor Revenue by Region: 2021-2032
- 5.3.1 Global Nociceptin Receptor Revenue by Region: 2021-2026
- 5.3.2 Global Nociceptin Receptor Revenue by Region: 2027-2032
- 5.4 North America Nociceptin Receptor Market Facts & Figures by Country
- 5.4.1 North America Nociceptin Receptor Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Nociceptin Receptor Sales by Country (2021-2032)
- 5.4.3 North America Nociceptin Receptor Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Nociceptin Receptor Market Facts & Figures by Country
- 5.5.1 Europe Nociceptin Receptor Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Nociceptin Receptor Sales by Country (2021-2032)
- 5.5.3 Europe Nociceptin Receptor Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Nociceptin Receptor Market Facts & Figures by Country
- 5.6.1 Asia Pacific Nociceptin Receptor Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Nociceptin Receptor Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Nociceptin Receptor Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Nociceptin Receptor Market Facts & Figures by Country
- 5.7.1 South America Nociceptin Receptor Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Nociceptin Receptor Sales by Country (2021-2032)
- 5.7.3 South America Nociceptin Receptor Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Nociceptin Receptor Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Nociceptin Receptor Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Nociceptin Receptor Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Nociceptin Receptor Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Nociceptin Receptor Sales by Type (2021-2032)
- 6.1.1 Global Nociceptin Receptor Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Nociceptin Receptor Sales Market Share by Type (2021-2032)
- 6.2 Global Nociceptin Receptor Revenue by Type (2021-2032)
- 6.2.1 Global Nociceptin Receptor Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Nociceptin Receptor Revenue Market Share by Type (2021-2032)
- 6.3 Global Nociceptin Receptor Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Nociceptin Receptor Sales by Application (2021-2032)
- 7.1.1 Global Nociceptin Receptor Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Nociceptin Receptor Sales Market Share by Application (2021-2032)
- 7.2 Global Nociceptin Receptor Revenue by Application (2021-2032)
- 7.2.1 Global Nociceptin Receptor Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Nociceptin Receptor Revenue Market Share by Application (2021-2032)
- 7.3 Global Nociceptin Receptor Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Nociceptin Receptor Value Chain Analysis
- 8.1.1 Nociceptin Receptor Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Nociceptin Receptor Production Mode & Process
- 8.2 Nociceptin Receptor Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Nociceptin Receptor Distributors
- 8.2.3 Nociceptin Receptor Customers
9 Global Nociceptin Receptor Analyzing Market Dynamics
- 9.1 Nociceptin Receptor Industry Trends
- 9.2 Nociceptin Receptor Industry Drivers
- 9.3 Nociceptin Receptor Industry Opportunities and Challenges
- 9.4 Nociceptin Receptor Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst